Transcend Therapeutics

About:

Transcend Therapeutics offers novel pharmaceuticals for the critical care market.

Website: https://www.transcendtherapeutics.com/

Top Investors: Alumni Ventures, Advent International, FJ Labs, U.S. Department of Defense, Alpha Wave Global

Description:

Transcend Therapeutics, Inc. is engaged in the development of pharmaceuticals for the treatment of diseases caused by oxidative stress and resultant tissue damage. The company is engaged in the development of pharmaceuticals for the treatment of diseases caused by oxidative stress and resultant tissue damage. Transcend Therapeutics was established in 1992 in Waltham, Massachusetts.

Total Funding Amount:

$40M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

1992-01-01

Founders:

Kevin Ryan

Number of Employees:

1-10

Last Funding Date:

2024-10-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai